melatonin and rivastigmine

melatonin has been researched along with rivastigmine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Finkin-Groner, E; Ginsburg, I; Lerman, L; Nudelman, A; Shalom, H; Weill, T; Weinstock, M; Yanovsky, I; Zaikin, A; Zeeli, S1
Hu, Y; Li, Y; Peng, P; Sheng, R; Tang, L1
Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J1
GarcĂ­a-Borreguero, D; Serrano, C1
Carvalho, AF; Chen, TY; Chen, YW; Cheng, YS; Hsu, CW; Li, DJ; Liang, CS; Lin, PY; Matsuoka, YJ; Shiue, YL; Stubbs, B; Su, KP; Sun, CK; Tseng, PT; Tu, YK; Wu, YC; Yang, CP; Yeh, PY; Zeng, BY1
Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S1
Avidan, AY; Carandang, G; During, EH; Foldvary-Schaefer, N; Howell, M; Kazmi, U; Malkani, RG; McCarter, SJ; Ramar, K; Roland, JP; Zak, RS1

Reviews

5 review(s) available for melatonin and rivastigmine

ArticleYear
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
    Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20

    Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands

2019
Fluctuations in cognition and alertness in Parkinson's disease and dementia.
    Neurology, 2004, Oct-26, Volume: 63, Issue:8 Suppl 3

    Topics: Awareness; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Humans; Lewy Body Disease; Melatonin; Multicenter Studies as Topic; Parkinson Disease; Phenylcarbamates; Phototherapy; Randomized Controlled Trials as Topic; Rivastigmine

2004
The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
    Current neuropharmacology, 2022, Volume: 20, Issue:10

    Topics: Alzheimer Disease; Cognition; Humans; Melatonin; Network Meta-Analysis; Randomized Controlled Trials as Topic; Rivastigmine

2022
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:10

    Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic

2022
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023, 04-01, Volume: 19, Issue:4

    Topics: Adult; Clonazepam; Humans; Melatonin; REM Sleep Behavior Disorder; Rivastigmine; Sleep; United States

2023

Other Studies

2 other study(ies) available for melatonin and rivastigmine

ArticleYear
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.
    Journal of medicinal chemistry, 2012, Dec-13, Volume: 55, Issue:23

    Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Carbamates; Chickens; Cholinesterase Inhibitors; Humans; Indoles; Neurons

2012
Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Curcumin; Dose-Response Relationship, Drug; Drug Design; Ligands; Molecular Docking Simulation; Molecular Structure; Phenylcarbamates; Rivastigmine; Structure-Activity Relationship

2014